Band 4+: The chart below shows how much money five big pharmaceutical companies spent on research in 2012 and 2018 and gives an estimate of the amounts spent in 2022. Describe the data providing an overview of the general trends, reporting the main features, and making comparisons.

The bar graph to illustrate quantity money, that severel pharmaceutical firms spent on research in 2012, 2018 and 2022.

To begin with, that Pharm company was leader among of all firms in question in 2012 and quantity spent money on research was about 9$bn, Fleming had slightly less money on researh in this year. And both firms, that called Novas and Avicenna spent approximately 3$bn. Biopharm line shows, that this company practically not spent money on research in 2012. But in 2018, all indications changed. Leader became Novas firm and it gave on research about 17$bn. All different companies also increased their money on research about in several once. And 2022 is very interesting period in question, becouse company, it called Novas decided spent approximately 57$bn, so Novas line did boom in this bar chart in 2022. Fleming company had secend place in this list. And other firms twice rised and it spent about 22-25$bn.

To sum up, all companies of this periods in question constantly increased quantity money, that it spent on research.